** Shares of medical device maker Inogen rise 10.6% to $9.49 premarket
** Co says its device for clearing mucus from lungs has received FDA 510(k) approval
** FDA 510(k) approval is a process where a medical device is shown to be safe and similar to an existing device before it can be sold
** The device, SIMEOX 200 Airway Clearance Device, helps improve bronchial drainage in patients with chronic respiratory diseases - INGN
** The device is intended for patients who can cough on their own - INGN
** Co plans a limited launch of the device at targeted sites in 2025
** As of last close, stock has risen 56.3% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。